Insight Molecular Diagnostics Income Statement (2020-2025) | IMDX

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.02M0.14M0.56M0.50M1.12M2.03M0.98M3.59M1.42M0.24M0.07M0.27M0.30M0.46M0.43M0.31M0.18M0.10M0.12M1.49M2.14M0.52M0.26M
Cost of Revenue 1.49M1.56M1.57M1.87M2.25M2.67M2.93M3.31M3.24M0.18M0.41M0.33M0.69M0.81M0.71M0.58M0.85M0.85M1.04M1.20M1.21M1.46M1.39M
Gross Profit -1.47M-0.16M-0.05M-0.21M0.08M-0.39M-0.87M2.60M-0.53M0.03M-0.27M-0.03M0.01M0.27M0.25M-0.12M0.04M0.05M0.05M0.59M1.32M0.35M0.14M
Operating items
Research & Development 2.16M3.23M2.62M1.80M3.36M2.54M3.14M4.59M5.13M2.44M1.47M1.38M2.13M2.44M2.19M2.55M2.31M2.45M2.82M2.26M2.92M3.28M3.88M
Selling, General & Administrative 4.62M3.76M5.00M3.41M4.76M7.93M5.50M4.14M5.65M5.45M5.70M5.09M3.41M3.53M2.49M1.75M2.67M2.41M2.56M2.56M3.12M2.65M2.54M
Other Operating Expenses 1.66M1.56M-1.41M0.84M3.31M2.70M4.10M9.06M-1.42M-6.23M-5.74M5.16M-11.38M2.60M2.09M11.76M4.33M-0.18M8.18M29.41M2.08M4.26M4.76M
Operating Expenses 8.45M8.55M6.20M6.05M11.44M13.17M12.74M17.79M9.36M1.66M1.44M11.62M-5.84M8.57M6.76M16.06M9.31M4.68M13.56M34.22M8.12M10.19M11.19M
Operating Income -8.43M-8.77M-6.24M-6.27M-11.36M-13.57M-13.60M-35.68M-9.89M-1.63M-1.71M-11.65M5.85M-8.29M-6.51M-16.18M-9.27M-4.63M-13.52M-33.63M-6.80M-9.84M-11.05M
EBIT -8.43M-8.77M-6.24M-6.27M-11.36M-13.57M-13.60M-35.68M-9.89M-1.63M-1.71M-11.65M5.85M-8.29M-6.51M-16.18M-9.27M-4.63M-13.52M-33.63M-6.80M-9.84M-11.05M
Non-operating items
Non Operating Investment Income -0.05M0.02M0.02M0.32M0.21M0.17M-0.14M-0.02M-0.33M0.01M-0.16M0.01M0.12M-0.02M-0.09M-0.07M
Other Non Operating Income 0.01M0.02M0.00M-0.00M0.00M1.14M-0.01M-0.04M0.28M0.06M-0.37M-0.00M-0.00M0.13M0.27M0.15M0.11M0.05M0.15M0.16M0.12M0.22M
Non Operating Income -0.40M-0.34M-0.54M-0.20M-0.12M1.28M-0.20M-0.11M-0.40M0.28M-0.11M-0.92M0.11M-0.04M0.13M0.27M0.15M0.11M0.05M0.15M0.16M0.12M0.22M
Net income details
EBT -8.83M-9.11M-6.78M-6.47M-11.48M-12.29M-13.80M-35.79M-10.29M-1.36M-1.82M-12.02M5.96M-8.33M-6.49M-16.18M-9.13M-4.63M-13.52M-33.63M-6.80M-9.84M-11.05M
Tax Provisions 1.09M-2.19M0.16M-7.56M1.79M-0.10M
Profit After Tax -7.73M-9.11M-6.78M-6.31M-3.92M-10.49M-13.80M-35.88M-10.29M-8.30M-9.33M-44.98M5.96M-8.33M-6.49M-15.99M-9.13M-4.53M-13.49M-33.51M-6.67M-9.74M-10.85M
Equity Income -0.33M-0.30M-0.48M-0.43M-0.27M
Income from Continuing Operations -9.92M-6.92M-6.78M-6.63M-3.92M-14.08M-13.80M-35.69M-10.29M-1.36M-1.82M-12.02M5.96M-8.33M-6.49M-16.18M-9.13M-4.63M-13.52M-33.63M-6.80M-9.84M-11.05M
Consolidated Net Income -9.92M-6.92M-6.78M-6.63M-3.92M-14.08M-13.80M-35.69M-10.29M-6.88M-7.51M-32.96M-2.93M-8.33M-6.49M-16.18M-9.13M-4.63M-13.52M-33.63M-6.80M-9.84M-11.05M
Income towards Parent Company -9.92M-6.92M-6.78M-6.63M-3.92M-14.08M-13.80M-35.69M-10.29M-6.88M-7.51M-32.96M-2.93M-8.33M-6.49M-16.18M-9.13M-4.63M-13.52M-33.63M-6.80M-9.84M-11.05M
Net Income towards Common Stockholders -9.92M-6.92M-6.78M-6.63M-3.92M-14.08M-13.80M-35.88M-10.29M-10.29M-9.63M-45.20M0.00M-8.64M-6.69M-16.18M-9.34M-4.59M-13.49M-33.63M-6.67M-9.74M-10.85M
Additional items
EPS (Basic) -0.130.14-0.10-0.10-0.050.12-0.15-0.40-0.11-1.48-1.624.560.82-1.07-0.81-1.96-1.13-0.36-0.98-2.00-0.26-0.30-0.34
EPS (Weighted Average and Diluted) -0.11-2.15-1.62-8.160.82-1.07-0.81-2.11-1.13-0.36-0.98-2.57-0.26-0.30-0.34
Shares Outstanding (Weighted Average) 3.12M3.36M3.36M3.36M4.45M4.49M4.58M4.61M4.61M5.93M5.93M5.96M5.93M8.24M8.24M8.27M8.26M13.36M13.37M16.84M28.60M28.60M28.62M
Shares Outstanding (Diluted Average) 92.24M0.01M0.01M5.54M5.96M8.09M8.26M7.65M8.26M12.87M13.71M13.07M25.69M32.02M32.03M
EBITDA -8.43M-8.77M-6.24M-6.27M-11.36M-13.57M-13.60M-35.68M-9.89M-1.63M-1.71M-11.65M5.85M-8.29M-6.51M-16.18M-9.27M-4.63M-13.52M-33.63M-6.80M-9.84M-11.05M
Tax Rate 24.04%65.87%0.27%